Stereotactic MR-guided adaptive radiotherapy could prove a safe and effective treatment option for patients with centrally ...

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

A UN report reveals that only a small proportion of secondary cancers in survivors are related to radiation therapy.

A long-term analysis of patients with early-stage non-small cell lung cancer showed those who received radiation achieved ...

A simultaneous or sequential combination of brentuximab vedotin and radiotherapy is feasible and well tolerated in patients ...

In standard radiotherapy, the radiation interacts with water in tissue, creating electrons or reactive oxygen species that ...

Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but ...

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of differentiated targeted radiotherapies, today highlighted new preclinical data for ...

Nanobiotix has completed the transfer of NANORAY-312 sponsorship, initiated in 3Q2024, in the majority of regions along with the transfer of full operational control of the Phase 3 clinical trial to ...

Nanobiotix S.A. has surged on strong NBTXR3 data, but its sole asset is out-licensed to Johnson & Johnson. Learn more about ...